Aspirin-sensitive versus non-aspirin-sensitive nasal polyp patients: Analysis of leukotrienes/Fas and Fas-ligand expression

被引:10
作者
Ziroli, NE
Na, H
Chow, JM
Stankiewicz, JA
Samter, M
Young, MRI
机构
[1] Loyola Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Stritch Sch Med, Maywood, IL 60153 USA
[2] Chosun Univ, Dept Otolaryngol, Kwangju 501759, South Korea
[3] Edward Hines Jr VA Hosp, Hines, IL USA
关键词
D O I
10.1067/mhn.2002.121913
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVE: The goal of the present study was to identify levels of leukotrienes released by leukocytes, and nasal polyps from aspirin-sensitive patients (ASPs) and non-aspirin-sensitive patients (NASPs) after exposure to various concentrations of aspirin. Eosinophll expressions of apoptosis regulators were also compared. STUDY DESIGN AND SETTING: Leukotriene release from nasal polyps and leukocytes of ASPs and NASPs was measured after exposure to differing concentrations of aspirin. Eosinophils were analyzed for Fas and Fas ligand receptors using flow cytometry. RESULTS: NASPs showed increased leukotriene release from nasal polyps on increased aspirin exposure. Polyps from ASPs did not show any change. ASPs showed greater leukotriene release from blood on increasing aspirin exposure compared with NASPs. Flow cytometric analysis showed eosinophils in the peripheral blood of ASPs have decreased Fas expression compared with those of NASPs. CONCLUSIONS: This study showed differences in leukotriene release and eosinophil apoptosis between ASPs and NASPs. SIGNIFICANCE: These findings suggest a role of leukotrienes and eosinophils in aspirin sensitivity mechanisms in blood.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 22 条
[11]  
LEFF AR, 1990, PERSPECT BIOL MED, V33, P292
[12]   INDUCTION OF APOPTOSIS IN HUMAN EOSINOPHILS BY ANTI-FAS ANTIBODY TREATMENT IN-VITRO [J].
MATSUMOTO, K ;
SCHLEIMER, RP ;
SAITO, H ;
IIKURA, Y ;
BOCHNER, BS .
BLOOD, 1995, 86 (04) :1437-1443
[13]   RELEASE OF PEPTIDE LEUKOTRIENE INTO NASAL SECRETIONS AFTER LOCAL INSTILLATION OF ASPIRIN IN ASPIRIN-SENSITIVE ASTHMATIC-PATIENTS [J].
PICADO, C ;
RAMIS, I ;
ROSELLO, J ;
PRAT, J ;
BULBENA, O ;
PLAZA, V ;
MONTSERRAT, JM ;
GELPI, E .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (01) :65-69
[14]   Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood [J].
Pizzichini, E ;
Pizzichini, MMM ;
Efthimiadis, A ;
Dolovich, J ;
Hargreave, FE .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (04) :539-544
[15]   INTOLERANCE TO ASPIRIN - CLINICAL STUDIES AND CONSIDERATION OF ITS PATHOGENESIS [J].
SAMTER, M ;
BEERS, RF .
ANNALS OF INTERNAL MEDICINE, 1968, 68 (05) :975-+
[16]  
Schmid M, 1999, ACTA OTO-LARYNGOL, V119, P277
[17]   ROLE OF LIPOXYGENASE METABOLITES IN PLATELET-ACTIVATING FACTOR-INDUCED AND ANTIGEN-INDUCED BRONCHIAL HYPERRESPONSIVENESS AND EOSINOPHIL INFILTRATION [J].
SEEDS, EAM ;
KILFEATHER, S ;
OKIJI, S ;
DONIGIGALE, D ;
PAGE, CP .
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1995, 293 (04) :369-376
[18]   COMPARISON OF ARACHIDONIC-ACID METABOLISM IN NASAL POLYPS AND EOSINOPHILS [J].
SMITH, DM ;
GERRARD, JM ;
WHITE, JG .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1987, 82 (01) :83-88
[19]  
Spector SL, 1995, ANN ALLERG ASTHMA IM, V75, P463
[20]   Aspirin-induced asthma: Advances in pathogenesis and management [J].
Szczeklik, A ;
Stevenson, DD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (01) :5-13